In vitro activity of telavancin against resistant gram-positive bacteria

被引：76

作者：

Krause, Kevin M. ^{[1
]}

Renelli, Marika ^{[1
]}

Difuntorum, Stacey ^{[1
]}

Wu, Terry X. ^{[1
]}

Debabov, Dmitri V. ^{[1
]}

Benton, Bret M. ^{[1
]}

机构：

[1] Theravance Inc, San Francisco, CA 94080 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 07期

关键词：

D O I：

10.1128/AAC.01398-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activity of telavancin was tested against 743 predominantly antimicrobial-resistant, gram-positive isolates. Telavancin was highly active against methicillin-resistant staphylococci (MIC90, 0.5 to 1 mu g/ml), streptococci (all MICs, <= 0.12 mu g/ml), and VanB-type enterococci (all MICs, <= 2 mu g/ml). Time-kill studies demonstrated the potent bactericidal activity of telavancin.

引用

页码：2647 / 2652

页数：6

共 13 条

[1] [Anonymous], 1999, METHODS DETERMINING
[2] Gram-positive resistance: challenge for the development of new antibiotics
Baquero, F
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 1 - 6
[3] Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications
Chambers, HF
[J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) : 781 - +
[4] Clinical and laboratory Standards Institute, 2007, M100S17 CLSI
[5] Clinical and Laboratory Standards Institute, 2006, M7A7 CLSI
[6] In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
Goldstein, EJC
Citron, DM
Merriam, CV
Warren, YA
Tyrrell, KL
Fernandez, HT
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2149 - 2152
[7] The emergence and evolution of methicillin-resistant Staphylococcus aureus
Hiramatsu, K
Cui, L
Kuroda, M
Ito, T
[J]. TRENDS IN MICROBIOLOGY, 2001, 9 (10) : 486 - 493
[8] In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe
Jansen, W. T. A.
Verel, A.
Verhoef, J.
Milatovic, D.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) : 3420 - 3424
[9] Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria
King, A
Phillips, I
Kaniga, K
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 797 - 803
[10] Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus
Leuthner, Kimberly D.
Cheung, Chrissy M.
Rybak, Michael J.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 338 - 343

← 1 2 →